Serum glucose and insulin are associated with QTc and RR intervals in nondiabetic elderly

European Journal of Endocrinology

Volumn 162, Issue 2, 2010, Pages 241-248

  Van Noord, Charlotte ^a,b   Sturkenboom, Miriam C J M ^a   Straus, Sabine M J M ^a,b   Hofman, Albert ^a   Kors, Jan A ^a   Witteman, Jacqueline C M ^a   Stricker, Bruno H Ch ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDICINES EVALUATION BOARD   (Netherlands)

^c Inspectorate for Health Care   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RATE CORRECTED QT INTERVAL PROLONGATION; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; RR INTERVAL; RR INTERVAL SHORTENING; SUDDEN DEATH; SYMPATHETIC TONE;

AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; LINEAR MODELS; LONG QT SYNDROME; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 75149149987     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0878     Document Type: Article

References (41)

1. Brown DW, Giles WH, Greenlund KJ, Valdez R & Croft JB. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. Journal of Cardiovascular Risk 2001 8 227-233.
2. Solini A, Passaro A, D'Elia K, Calzoni F, Alberti L & Fellin R. The relationship of plasma glucose and electrocardiographic parameters in elderly women with different degrees of glucose tolerance. Aging 2000 12 249-255.
3. Lasser KE, Allen PD,Woolhandler SJ, Himmelstein DU,Wolfe SM & Bor DH. Timing of new black box warnings and withdrawals for prescription medications. Journal of the American Medical Association 2002 287 2215-2220.
4. Roden DM. Drug-induced prolongation of the QT interval. New England Journal of Medicine 2004 350 1013-1022.
5. Al-Khatib SM, LaPointe NM, Kramer JM & Califf RM. What clinicians should know about the QT interval. Journal of the American Medical Association 2003 289 2120-2127.
6. Yap YG & Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003 89 1363-1372.
7. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH & Witteman JC. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. Journal of the American College of Cardiology 2006 47 362-367.
8. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J & Kromhout D. QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen Elderly Study. Diabetes 1996 45 376-380.
9. Lefrandt JD, Diercks GF, van Boven AJ, Crijns HJ, van Gilst WH & Gans RO. High fasting glucose and QTc duration in a large healthy cohort. Diabetologia 2000 43 1332-1333.
10. Laitinen T, Vauhkonen I, Niskanen L, Hartikainen J, Uusitupa M & Laakso M. Prolonged corrected QT interval is associated with acute and chronic hyperinsulinemia in nondiabetic subjects. Diabetes Care 2003 26 2480-2481.
11. Schroeder EB, Chambless LE, Liao D, Prineas RJ, Evans GW, Rosamond WD & Heiss G. Atherosclerosis risk in communities: diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2005 28 668-674.
12. Festa A, D'Agostino R Jr, Hales CN, Mykkanen L & Haffner SM. Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects. Diabetes Care 2000 23 624-628.
13. Hofman A, Grobbee DE, de Jong PT & van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. European Journal of Epidemiology 1991 7 403-422.
14. Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR & Witteman JC. The Rotterdam Study: objectives and design update. European Journal of Epidemiology 2007 22 819-829.
15. WHO: Diabetes Mellitus. Technical Reports Series 894. Geneva, World Health Organisation, 1985.
16. Kulan K, Ural D, Komsuoglu B, Agacdiken A, Goldeli O & Komsuoglu SS. Significance of QTc prolongation on ventricular arrhythmias in patients with left ventricular hypertrophy secondary to essential hypertension. International Journal of Cardiology 1998 64 179-184.
17. Piotrowicz K, Zareba W, McNitt S & Moss AJ. Repolarization duration in patients with conduction disturbances after myocardial infarction. American Journal of Cardiology 2007 99 163-168.
18. de Bruyne MC, Kors JA, Hoes AW, Kruijssen DA, Deckers JW, Grosfeld M, van Herpen G, Grobbee DE & van Bemmel JH. Diagnostic interpretation of electrocardiograms in populationbased research: computer program research physicians, or cardiologists? Journal of Clinical Epidemiology 1997 50 947-952.
19. van Bemmel JH, Kors JA & van Herpen G. Methodology of the modular ECG analysis system MEANS. Methods of Information in Medicine 1990 29 346-353.
20. Willems JL, Abreu-Lima C, Arnaud P, van Bemmel JH, Brohet C, Degani R, Denis B, Gehring J, Graham I, van Herpen G, Machado H, Macfarlane PW, Michaelis J, Moulopolis S, Rubel P & Zywietz C. The diagnostic performance of computer programs for the interpretation of electrocardiograms. New England Journal of Medicine 1991 325 1767-1773.
21. Willems JL, Arnaud P, van Bemmel JH, Bourdillon PJ, Degani R, Denis B, Graham I, Harms FM, Macfarlane PW, Mazzocca G, Meyer J & Zywietz C. A reference data base for multilead electrocardiographic computer measurement programs. Journal of the American College of Cardiology 1987 10 1313-1321.
22. Bazett HC. The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. Journal of Physiology 1920 53 320-339.
23. Myerburg RJ & Castellanos A. Language and interpretation of clinical trial outcomes: alternates, surrogates, and composites. Heart Rhythm 2004 1 538-539.
24. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, Camm AJ, Cappato R, Cobbe SM, Di Mario C, Maron BJ, McKenna WJ, Pedersen AK, Ravens U, Schwartz PJ, Trusz-Gluza M, Vardas P,Wellens HJ & Zipes DP. Task force on sudden cardiac death of the European Society of Cardiology. European Heart Journal 2001 22 1374-1450.
25. Neeley WE. Simple automated determination of serum or plasma glucose by a hexokinase-glucose-6-phosphate dehydrogenase method. Clinical Chemistry 1972 18 509-515.
26. The Expert Committee on the Diagnosis and Classification of Diabetes. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183-1197.
27. WHO: World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. Journal of Hypertension 1999 17 151-183.
28. Bots ML, Hoes AW, Koudstaal PJ, Hofman A & Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997 96 1432-1437.
29. Vliegenthart R, Oudkerk M, Song B, van der Kuip DA, Hofman A & Witteman JC. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. European Heart Journal 2002 23 1596-1603.
30. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC & Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. The Rotterdam Study. European Heart Journal 2004 25 1614-1619.
31. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A & Grobbee DE. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. European Heart Journal 1999 20 447-455.
32. Expert Panel on Detection EaToHBCiA. Executive summary of The third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497.
33. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D & Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. New England Journal of Medicine 2005 352 1951-1958.
34. Shaper AG, Wannamethee G, Macfarlane PW & Walker M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. British Heart Journal 1993 70 49-55.
35. Kannel WB, Kannel C, Paffenbarger RS Jr & Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. American Heart Journal 1987 113 1489-1494.
36. Marfella R, Rossi F & Giugliano D. Hyperglycemia and QT interval: time for re-evaluation. Diabetes, Nutrition & Metabolism 2001 14 63-65.
37. + channel function by hypoglycemia and hyperglycemia, Similar phenotypes but different mechanisms. Journal of Biological Chemistry 2003 278 10417-10426.
38. Ben-David J & Zipes DP. Differential response to right and left ansae subclaviae stimulation of early after depolarizations and ventricular tachycardia induced by cesium in dogs. Circulation 1988 78 1241-1250.
39. Anderson EA, Hoffman RP, Balon TW, Sinkey CA & Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. Journal of Clinical Investigation 1991 87 2246-2252.
40. Oka H, Mochio S, Sato K, Sato H & Katayama K. Prolongation of QTc interval and autonomic nervous dysfunction in diabetic patients. Diabetes Research and Clinical Practice 1996 31 63-70.
41. 4 levels are associated with QTc prolongation in males. Journal of Endocrinology 2008 198 253-260.